Physician profile
Joseph E Goin
NPI 1730189408
$5,643.60
in general payments reported to CMS, 2019-2025
47 companies · $722 in 2025
The $722 reported for 2025 was more than what 89% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $315 · 2021: $814 · 2022: $946 · 2023: $1,355 · 2024: $1,127 · 2025: $722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,203.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $897.71 | 2019-2025 | Trelegy Ellipta, Bexsero, Rotarix |
| Tris Pharma INC | $790.73 | 2020-2025 | Dyanavel Xr, Onyda Xr |
| Supernus Pharmaceuticals, INC. | $594.82 | 2021-2024 | Qelbree, Qelbree |
| Abbvie INC. | $404.15 | 2021-2024 | |
| Mylan Specialty L.P. | $202.97 | 2021-2024 | Yupelri |
| Pfizer INC. | $187.46 | 2020-2025 | |
| Inspire Medical Systems, INC. | $175.98 | 2024-2025 | Inspire |
| Sunovion Pharmaceuticals INC. | $148.95 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $140.01 | 2019-2024 | Jornay Pm |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $139.05 | 2022-2024 | Caplyta |
| Astrazeneca Pharmaceuticals LP | $134.92 | 2019-2025 | Airsupra, Breztri |
| Exact Sciences Corporation | $131.91 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Corium, LLC | $122.37 | 2022-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $111.46 | 2019-2024 | Verquvo, Vaxelis, Vaxneuvance |
| Dexcom, INC. | $97.88 | 2024-2025 | Dexcom G6 Transmitter |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $96.66 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cranial Technologies, INC | $96.54 | 2019-2023 | Doc Band |
| Lilly USA, LLC | $96.20 | 2020-2024 | Mounjaro |
| Si-Bone, INC. | $94.28 | 2022 | |
| Vanda Pharmaceuticals INC. | $92.52 | 2021-2022 | |
| Novo Nordisk INC | $89.25 | 2020-2025 | |
| Otsuka America Pharmaceutical, INC. | $74.04 | 2019-2024 | Abilify Maintena |
| Sanofi Pasteur INC. | $72.21 | 2019-2025 | |
| Eisai INC. | $59.92 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.25 | 2020-2025 | Xifaxan |
| Astellas Pharma US INC | $47.12 | 2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $39.08 | 2020-2021 | |
| Tactile Systems Technology INC | $36.76 | 2022-2025 | Nimbl, Flexitouch Plus |
| Hologic Sales and Service, LLC | $35.59 | 2019-2021 | |
| Organon LLC | $34.80 | 2021-2023 | Nexplanon |
| Ars Pharmaceuticals Operations, INC. | $31.44 | 2025 | Neffy |
| Sumitomo Pharma America, INC. | $29.75 | 2025 | Gemtesa |
| Alnylam Pharmaceuticals INC. | $28.91 | 2023 | Oxlumo |
| Abbott Laboratories | $24.62 | 2022 | |
| Nestle Healthcare Nutrition INC. | $23.53 | 2023 | |
| Edwards Lifesciences Corporation | $22.46 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Verrica Pharmaceuticals INC. | $21.52 | 2024 | Ycanth |
| Adlon Therapeutics L.P. | $21.49 | 2021 | |
| Neurocrine Biosciences, INC. | $19.89 | 2025 | |
| Medtronic, INC. | $19.45 | 2024 | Venaseal |
| Ermi LLC | $18.09 | 2019 | |
| Amarin Pharma, INC. | $17.50 | 2020 | |
| Livanova USA, INC. | $15.47 | 2019 | |
| Seqirus USA INC | $14.51 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Cumberland Pharmaceuticals, INC. | $12.45 | 2019 | |
| Allergan, INC. | $12.08 | 2020 | |
| Meridian Bioscience INC. | $8.85 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Goin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.